Allurion Technologies, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Allurion Technologies, Inc. (ALUR) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.36 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-05-15
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.36M.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$1.96M, a 152.86% decline year-over-year.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.14M.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-06-30 was -$2.76M.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$5.04M.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$4.07M, a 485.34% decline from fiscal 2023.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.06M, a 87.05% decline from fiscal 2022.
- Allurion Technologies, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $8.16M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$1.36M 10-Q · filed 2026-05-15 | -$3.32M derived: sum of 2 quarters · filed 2026-05-15 | -$2.18M derived: sum of 3 quarters · filed 2026-05-15 | -$4.94M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$815.00K derived: sum of 2 quarters · filed 2026-03-30 | -$3.58M derived: sum of 3 quarters · filed 2026-03-30 | -$5.04M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$1.62M derived: sum of 2 quarters · filed 2025-11-17 | -$3.09M 10-Q · filed 2025-11-17 | $617.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$4.23M 10-Q · filed 2025-08-19 | -$526.00K derived: sum of 3 quarters · filed 2026-05-15 | -$6.59M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$1.47M 10-Q · filed 2026-05-15 | $2.24M derived: sum of 2 quarters · filed 2026-05-15 | -$3.83M derived: sum of 3 quarters · filed 2026-05-15 | -$4.55M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.36M derived: sum of 2 quarters · filed 2026-03-30 | -$3.08M derived: sum of 3 quarters · filed 2026-03-30 | -$4.07M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$6.06M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | -$6.79M derived: sum of 2 quarters · filed 2025-11-17 | -$7.78M 10-Q · filed 2025-11-17 | -$11.60M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$724.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$1.71M 10-Q/A · filed 2025-08-28 | -$5.54M derived: sum of 3 quarters · filed 2025-08-28 | -$3.82M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$989.00K 10-Q/A · filed 2025-08-28 | -$4.81M derived: sum of 2 quarters · filed 2025-08-28 | -$3.09M derived: sum of 3 quarters · filed 2025-08-28 | $519.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$3.82M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$2.10M derived: sum of 2 quarters · filed 2025-08-28 | $1.51M derived: sum of 3 quarters · filed 2025-08-28 | $1.06M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $1.72M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $5.33M derived: sum of 2 quarters · filed 2025-08-28 | $4.88M 10-Q/A · filed 2025-08-28 | $7.36M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $3.61M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $3.16M 10-Q/A · filed 2025-08-28 | $5.64M derived: sum of 3 quarters · filed 2025-08-28 | $9.25M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | -$451.00K 10-Q/A · filed 2025-08-28 | $2.03M derived: sum of 2 quarters · filed 2025-08-28 | $5.64M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | $2.48M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $6.09M derived: sum of 2 quarters · filed 2025-08-28 | $8.16M 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | $3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $5.68M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $2.08M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |